Company Valuation: Theralase Technologies Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 76.6 69.28 39.98 65.66 43.71 58.99 - -
Change - -9.56% -42.29% 64.23% -33.43% 34.96% - -
Enterprise Value (EV) 76.6 69.28 39.98 65.66 43.71 58.99 58.99 58.99
Change - -9.56% -42.29% 64.23% -33.43% 34.96% 0% 0%
P/E -17x -12.8x -7.95x -14.7x -10.3x -19x 9.5x 3.8x
PBR 15.1x 21.5x 17.5x 31.9x 23.5x 6.33x 3.8x 1.73x
PEG - -0.9x 0.7x 0.8x 0.9x 0.5x -0x 0x
Capitalization / Revenue 98.1x 60.8x 37.4x 63.5x 53.5x 75.1x 1.74x 0.79x
EV / Revenue 0x 0x 0x 0x 0x 75.1x 1.74x 0.79x
EV / EBITDA - - - - - - - -
EV / EBIT - - - - - - - -
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 -0.022 -0.025 -0.022 -0.018 -0.016 -0.01 0.02 0.05
Distribution rate - - - - - - - -
Net sales 1 0.7806 1.139 1.07 1.033 0.8165 0.786 33.89 74.69
EBITDA - - - - - - - -
EBIT - - - - - - - -
Net income 1 -4.411 -5.235 -4.571 -4.256 -4.121 -4.124 6.901 20.1
Net Debt - - - - - - - -
Reference price 2 0.3750 0.3200 0.1750 0.2650 0.1650 0.1900 0.1900 0.1900
Nbr of stocks (in thousands) 204,276 216,503 228,461 247,780 264,909 310,483 - -
Announcement Date 29/04/22 26/04/23 27/03/24 12/03/25 04/05/26 - - -
1CAD in Million2CAD
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
-19x - - - 42.16M
34.66x5.93x22.65x0.27% 251B
53.97x13.11x28.13x-.--% 162B
35.98x6.85x21.44x0.64% 159B
18.26x3.59x11.7x-.--% 64.7B
39.97x8.04x25.42x-.--% 57.97B
22.04x2.61x13.16x2.29% 56.21B
47.48x11.69x25.77x-.--% 50.21B
33.47x6.63x22.53x0.6% 48.43B
110.61x7.51x22.85x-.--% 44.51B
Average 37.74x 7.33x 21.52x 0.42% 89.45B
Weighted average by Cap. 41.20x 7.60x 22.40x 0.37%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Theralase Technologies Inc.

Historical PBR trend

Valuation ratios - PBR - Theralase Technologies Inc.

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Theralase Technologies Inc.

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Theralase Technologies Inc.

  1. Stock Market
  2. Stocks
  3. TLT Stock
  4. Valuation Theralase Technologies Inc.